Gland Pharma

Highly Engaged Employees

Gland Pharma, established in 1978, is a rapidly growing global manufacturer specializing in generic injectable pharmaceuticals. Headquartered in Hyderabad, India, the company has built a strong reputation within the Healthcare and Pharmaceuticals sectors. Its core business revolves around developing and producing complex injectable formulations, catering to critical therapeutic areas such as oncology and ophthalmics, leveraging robust R&D and manufacturing capabilities.

The company's expertise is underpinned by advanced manufacturing infrastructure and a commitment to high-quality, affordable products. Gland Pharma supplies its extensive portfolio to over 60 countries, including major markets like the United States, Europe, Canada, and Australia, operating primarily on a business-to-business model. Its product focus includes small volume generic molecules, addressing diverse pharmaceutical needs across the globe.

Employing between 1,000-5,000 individuals, Gland Pharma exhibits substantial operational scale and a dedicated workforce. The company has attracted significant investment, notably a $200 million funding round in 2013 from KKR & Co. L.P., highlighting investor confidence in its growth trajectory. Interested parties can delve into detailed financial performance metrics via Explore financial highlights. To gain insight into the organizational structure and leadership driving its success, one can learn more by Meet Gland Pharma's team. The company is publicly traded under the ticker NSE: GLAND.